{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:06:40Z","timestamp":1791090400384,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T00:00:00Z","timestamp":1686441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T00:00:00Z","timestamp":1686441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["3 Biotech"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s13205-023-03648-2","type":"journal-article","created":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T07:01:10Z","timestamp":1686466870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["An overview of opportunistic fungal infections associated with COVID-19"],"prefix":"10.1007","volume":"13","author":[{"given":"Navidita","family":"Kangabam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8647-1767","authenticated-orcid":false,"given":"V.","family":"Nethravathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,11]]},"reference":[{"key":"3648_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.crbiot.2022.08.001","volume":"4","author":"N Akhtar","year":"2022","unstructured":"Akhtar N, Wani AK, Tripathi SK, Prakash A, Mannan MA (2022) The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review. Curr Res Biotechnol 4:337\u2013349","journal-title":"Curr Res Biotechnol"},{"issue":"2","key":"3648_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000489474","volume":"96","author":"A Alastruey-Izquierdo","year":"2018","unstructured":"Alastruey-Izquierdo A, Cadranel J, Flick H, Godet C, Hennequin C, Hoenigl M, Kosmidis C, Lange C, Munteanu O, Page I, Salzer HJF, on\u00a0behalf\u00a0of\u00a0CPAnet (2018) Treatment of chronic pulmonary aspergillosis: current standards and future perspectives. Respiration. 96(2):159\u2013170. https:\/\/doi.org\/10.1159\/000489474","journal-title":"Respiration."},{"issue":"15","key":"3648_CR3","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.3390\/jcm10153441","volume":"10","author":"H Ali Awan","year":"2021","unstructured":"Ali Awan H, Najmuddin Diwan M, Aamir A, Ali M, Di Giannantonio M, Ullah I, Shoib S, De Berardis D (2021) SARS-CoV-2 and the brain: What do we know about the causality of \u2018cognitive COVID? J Clin Med 10(15):3441. https:\/\/doi.org\/10.3390\/jcm10153441","journal-title":"J Clin Med"},{"issue":"Suppl 7","key":"3648_CR4","doi-asserted-by":"publisher","first-page":"S1591","DOI":"10.1093\/clinids\/11.supplement_7.s1591","volume":"11","author":"D Armstrong","year":"1989","unstructured":"Armstrong D (1989) Problems in management of opportunistic fungal diseases. Rev Infect Dis 11(Suppl 7):S1591\u2013S1599. https:\/\/doi.org\/10.1093\/clinids\/11.supplement_7.s1591","journal-title":"Rev Infect Dis"},{"key":"3648_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab510","author":"JW Baddley","year":"2021","unstructured":"Baddley JW, Thompson GR 3rd, Chen SC, White PL, Johnson MD, Nguyen MH, Schwartz IS, Spec A, Ostrosky-Zeichner L, Jackson BR, Patterson TF, Pappas PG (2021) Coronavirus disease 2019-associated invasive fungal infection. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/ofid\/ofab510","journal-title":"Open Forum Infect Dis."},{"issue":"Suppl 2","key":"3648_CR6","doi-asserted-by":"publisher","first-page":"ii13","DOI":"10.1093\/jac\/dkw392","volume":"71","author":"M Bassetti","year":"2016","unstructured":"Bassetti M, Peghin M, Timsit JF (2016) The current treatment landscape: candidiasis. J Antimicrob Chemother. 71(Suppl 2):ii13\u2013ii22. https:\/\/doi.org\/10.1093\/jac\/dkw392","journal-title":"J Antimicrob Chemother."},{"key":"3648_CR7","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852920002175","author":"D De Berardis","year":"2020","unstructured":"De Berardis D (2020) How concerned should we be about neurotropism of SARS-Cov-2? A brief clinical consideration of the possible psychiatric implications. CNS Spectrum. https:\/\/doi.org\/10.1017\/S1092852920002175","journal-title":"CNS Spectrum"},{"key":"3648_CR8","doi-asserted-by":"publisher","unstructured":"Bhatt K, Agolli A, Patel MH, et al. (2021) High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries (Craiova). 9(1):e126. https:\/\/doi.org\/10.15190\/d.2021.5","DOI":"10.15190\/d.2021.5"},{"issue":"3","key":"3648_CR9","doi-asserted-by":"publisher","first-page":"101007","DOI":"10.1016\/j.mycmed.2020.101007","volume":"30","author":"K Brunet","year":"2020","unstructured":"Brunet K, Rammaert B (2020) Mucormycosis treatment: recommendations, latest advances, and perspectives. J Mycol Med. 30(3):101007. https:\/\/doi.org\/10.1016\/j.mycmed.2020.101007","journal-title":"J Mycol Med."},{"issue":"1","key":"3648_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","volume":"10","author":"FB Cavassin","year":"2021","unstructured":"Cavassin FB, Ba\u00fa-Carneiro JL, Vilas-Boas RR, Queiroz-Telles F (2021) Sixty years of Amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections. Infect Dis Ther 10(1):115\u2013147. https:\/\/doi.org\/10.1007\/s40121-020-00382-7","journal-title":"Infect Dis Ther"},{"issue":"3","key":"3648_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3314\/jjmm.49.165","volume":"49","author":"A Chakrabarti","year":"2008","unstructured":"Chakrabarti A, Chatterjee SS, Shivaprakash MR (2008) Overview of opportunistic fungal infections in India. Nippon Ishinkin Gakkai Zasshi 49(3):165\u2013172. https:\/\/doi.org\/10.3314\/jjmm.49.165","journal-title":"Nippon Ishinkin Gakkai Zasshi"},{"key":"3648_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12281-018-0310-4","volume":"12","author":"S Challa","year":"2018","unstructured":"Challa S (2018) Pathogenesis and pathology of invasive aspergillosis. Curr Fungal Infect Rep 12:23\u201332. https:\/\/doi.org\/10.1007\/s12281-018-0310-4","journal-title":"Curr Fungal Infect Rep"},{"issue":"3","key":"3648_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1128\/CMR.00055-08","volume":"22","author":"TR Dagenais","year":"2009","unstructured":"Dagenais TR, Keller NP (2009) Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev 22(3):447\u2013465. https:\/\/doi.org\/10.1128\/CMR.00055-08","journal-title":"Clin Microbiol Rev"},{"key":"3648_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s43055-022-00694-3","volume":"53","author":"R Dubey","year":"2022","unstructured":"Dubey R, Sen KK, Mohanty SS et al (2022) The rising burden of invasive fungal infections in COVID-19, can structured CT thorax change the game. Egypt J Radiol Nucl Med 53:18. https:\/\/doi.org\/10.1186\/s43055-022-00694-3","journal-title":"Egypt J Radiol Nucl Med"},{"issue":"4","key":"3648_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1128\/CMR.12.4.501","volume":"12","author":"MA Ghannoum","year":"1999","unstructured":"Ghannoum MA, Rice LB (1999) Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12(4):501\u2013517. https:\/\/doi.org\/10.1128\/CMR.12.4.501","journal-title":"Clin Microbiol Rev"},{"key":"3648_CR16","doi-asserted-by":"publisher","unstructured":"Hassan MIA, Voigt K (2019) Pathogenicity patterns of mucormycosis: epidemiology, interaction with immune cells and virulence factors. Med Mycol. 57(Supplement_2):S245\u2013S256. https:\/\/doi.org\/10.1093\/mmy\/myz011","DOI":"10.1093\/mmy\/myz011"},{"key":"3648_CR17","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","volume":"7","author":"M Hoenigl","year":"2022","unstructured":"Hoenigl M, Seidel D, Sprute R et al (2022) COVID-19-associated fungal infections. Nat Microbiol 7:1127\u20131140. https:\/\/doi.org\/10.1038\/s41564-022-01172-2","journal-title":"Nat Microbiol"},{"key":"3648_CR18","doi-asserted-by":"publisher","unstructured":"Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP (2012) Pathogenesis of mucormycosis. Clin Infect Dis 54 (Suppl 1):S16\u201322. https:\/\/doi.org\/10.1093\/cid\/cir865","DOI":"10.1093\/cid\/cir865"},{"issue":"3","key":"3648_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","volume":"70","author":"C Kosmidis","year":"2015","unstructured":"Kosmidis C, Denning DW (2015) The clinical spectrum of pulmonary aspergillosis. Thorax 70(3):270\u2013277. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-206291","journal-title":"Thorax"},{"issue":"121","key":"3648_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1183\/09059180.00001011","volume":"20","author":"M Kousha","year":"2011","unstructured":"Kousha M, Tadi R, Soubani AO (2011) Pulmonary aspergillosis: a clinical review. Eur Respir Rev 20(121):156\u2013174. https:\/\/doi.org\/10.1183\/09059180.00001011","journal-title":"Eur Respir Rev"},{"issue":"1","key":"3648_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3201\/eid2701.202896","volume":"27","author":"KA Marr","year":"2021","unstructured":"Marr KA, Platt A, Tornheim JA, Zhang SX, Datta K, Cardozo C, Garcia-Vidal C (2021) Aspergillosis complicating severe coronavirus disease. Emerg Infect Dis 27(1):18\u201325. https:\/\/doi.org\/10.3201\/eid2701.202896","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"3648_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4161\/viru.22913","volume":"4","author":"FL Mayer","year":"2013","unstructured":"Mayer FL, Wilson D, Hube B (2013) Candida albicans pathogenicity mechanisms. Virulence. 4(2):119\u201328. https:\/\/doi.org\/10.4161\/viru.22913","journal-title":"Virulence."},{"issue":"3","key":"3648_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ccm.2017.04.006","volume":"38","author":"JA McBride","year":"2017","unstructured":"McBride JA, Gauthier GM, Klein BS (2017) Clinical manifestations and treatment of blastomycosis. Clin Chest Med 38(3):435\u2013449. https:\/\/doi.org\/10.1016\/j.ccm.2017.04.006","journal-title":"Clin Chest Med"},{"issue":"1","key":"3648_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.idc.2015.10.012","volume":"30","author":"JE Nett","year":"2016","unstructured":"Nett JE, Andes DR (2016) Antifungal agents: spectrum of activity, pharmacology, and clinical indications. Infect Dis Clin North Am 30(1):51\u201383. https:\/\/doi.org\/10.1016\/j.idc.2015.10.012","journal-title":"Infect Dis Clin North Am"},{"key":"3648_CR25","doi-asserted-by":"publisher","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","volume":"4","author":"PG Pappas","year":"2018","unstructured":"Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ (2018) Invasive candidiasis. Nat Rev Dis Prim 4:18026. https:\/\/doi.org\/10.1038\/nrdp.2018.26","journal-title":"Nat Rev Dis Prim"},{"issue":"2","key":"3648_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1086\/380796","volume":"38","author":"PG Pappas","year":"2004","unstructured":"Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE, Infectious Diseases Society of America (2004) Guidelines for treatment of candidiasis. Clin Infect Dis. 38(2):161\u201389. https:\/\/doi.org\/10.1086\/380796","journal-title":"Clin Infect Dis."},{"issue":"2","key":"3648_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/PAS.0b013e3181ca48a5","volume":"34","author":"AJ Patel","year":"2010","unstructured":"Patel AJ, Gattuso P, Reddy VB (2010) Diagnosis of blastomycosis in surgical pathology and cytopathology: correlation with microbiologic culture. Am J Surg Pathol 34(2):256\u2013261. https:\/\/doi.org\/10.1097\/PAS.0b013e3181ca48a5","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3648_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/13693786.2012.685960","volume":"51","author":"HS Randhawa","year":"2013","unstructured":"Randhawa HS, Chowdhary A, Kathuria S, Roy P, Misra DS, Jain S, Chugh TD (2013) Blastomycosis in India: report of an imported case and current status. Med Mycol 51(2):185\u2013192. https:\/\/doi.org\/10.3109\/13693786.2012.685960","journal-title":"Med Mycol"},{"key":"3648_CR29","doi-asserted-by":"publisher","unstructured":"Ravikant KT, Gupte S, et al (2015) A review on emerging fungal infections and their significance. J Bacteriol Mycol Open Access 1(2):39\u201341. https:\/\/doi.org\/10.15406\/jbmoa.2015.01.00009","DOI":"10.15406\/jbmoa.2015.01.00009"},{"issue":"5","key":"3648_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","volume":"41","author":"MM Roden","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ (2005) Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41(5):634\u2013653. https:\/\/doi.org\/10.1086\/432579","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"3648_CR31","doi-asserted-by":"publisher","first-page":"i35","DOI":"10.1093\/jac\/dkm429","volume":"61","author":"TR Rogers","year":"2008","unstructured":"Rogers TR (2008) Treatment of zygomycosis: current and new options. J Antimicrob Chemother 61(Suppl 1):i35-40. https:\/\/doi.org\/10.1093\/jac\/dkm429","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"3648_CR32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1128\/CMR.00056-09","volume":"23","author":"M Saccente","year":"2010","unstructured":"Saccente M, Woods GL (2010) Clinical and laboratory update on blastomycosis. Clin Microbiol Rev 23(2):367\u2013381. https:\/\/doi.org\/10.1128\/CMR.00056-09","journal-title":"Clin Microbiol Rev"},{"key":"3648_CR33","unstructured":"Sanjay G. Revankar (2021) Overview of fungal infections, last full review\/revision"},{"key":"3648_CR34","doi-asserted-by":"publisher","first-page":"17070","DOI":"10.1038\/srep17070","volume":"5","author":"SK Shrestha","year":"2015","unstructured":"Shrestha SK, Fosso MY, Garneau-Tsodikova S (2015) A combination approach to treating fungal infections. Sci Rep 5:17070. https:\/\/doi.org\/10.1038\/srep17070","journal-title":"Sci Rep"},{"key":"3648_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.15380\/2277-5706.JCSR.13.050","volume":"3","author":"T Singh","year":"2014","unstructured":"Singh T, Kashyap AK, Ahluwalia G, Chinna D, Sidhu SS (2014) Epidemiology of fungal infections in critical care setting of a tertiary care teaching hospital in North India: a prospective surveillance study. J Clin Scient Res 3:14\u201325","journal-title":"J Clin Scient Res"},{"key":"3648_CR36","doi-asserted-by":"publisher","unstructured":"Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G (2018) Challenges in the diagnosis and treatment of mucormycosis. Med Mycol 56(suppl_1):93\u2013101. https:\/\/doi.org\/10.1093\/mmy\/myx101","DOI":"10.1093\/mmy\/myx101"},{"key":"3648_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4103\/phrev.phrev_8_17","volume":"11","author":"S Soliman","year":"2017","unstructured":"Soliman S, Alnajdy D, El-Keblawy AA, Mosa KA, Khoder G, Noreddin AM (2017) Plants\u2019 natural products as alternative promising anti-Candida drugs. Phcog Rev 11:104\u2013122","journal-title":"Phcog Rev"},{"key":"3648_CR38","doi-asserted-by":"publisher","unstructured":"Spanakis EK, Aperis G, Mylonakis E (2006) New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clin Infect Dis 43(8):1060\u20131068. https:\/\/doi.org\/10.1086\/507891. Erratum in: Clin Infect Dis. 43(9):1232","DOI":"10.1086\/507891"},{"issue":"12","key":"3648_CR39","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1086\/599105","volume":"48","author":"B Spellberg","year":"2009","unstructured":"Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS (2009) Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 48(12):1743\u20131751. https:\/\/doi.org\/10.1086\/599105","journal-title":"Clin Infect Dis"},{"key":"3648_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/713687","author":"P Vandeputte","year":"2012","unstructured":"Vandeputte P, Ferrari S, Coste AT (2012) Antifungal resistance and new strategies to control fungal infections. Int J Microbiol. https:\/\/doi.org\/10.1155\/2012\/713687","journal-title":"Int J Microbiol."},{"issue":"3","key":"3648_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF, Infectious Diseases Society of America (2008) Treatment of aspergillosis: clinical practice guidelines of the infectious diseases Society of America. Clin Infect Dis. 46(3):327\u201360. https:\/\/doi.org\/10.1086\/525258","journal-title":"Clin Infect Dis."},{"issue":"4","key":"3648_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/diseases9040065","volume":"9","author":"F Yasmin","year":"2021","unstructured":"Yasmin F, Najeeb H, Naeem A, Dapke K, Phadke R, Asghar MS, Shah SMI, De Berardis D, Ullah I (2021) COVID-19 associated mucormycosis: a systematic review from diagnostic challenges to management. Diseases 9(4):65. https:\/\/doi.org\/10.3390\/diseases9040065","journal-title":"Diseases"},{"issue":"3","key":"3648_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.mycmed.2017.04.011","volume":"27","author":"M Zargaran","year":"2017","unstructured":"Zargaran M, Taghipour S, Kiasat N, Aboualigalehdari E, Rezaei-Matehkolaei A, Zarei Mahmoudabadi A, Shamsizadeh F (2017) Luliconazole, an alternative antifungal agent against Aspergillus terreus. J Mycol Med 27(3):351\u2013356. https:\/\/doi.org\/10.1016\/j.mycmed.2017.04.011","journal-title":"J Mycol Med"}],"container-title":["3 Biotech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-023-03648-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13205-023-03648-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-023-03648-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T05:19:07Z","timestamp":1688620747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13205-023-03648-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,11]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["3648"],"URL":"https:\/\/doi.org\/10.1007\/s13205-023-03648-2","relation":{},"ISSN":["2190-572X","2190-5738"],"issn-type":[{"value":"2190-572X","type":"print"},{"value":"2190-5738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,11]]},"assertion":[{"value":"24 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This work did not require ethical clearance since it is a review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"231"}}